Anthony J. Levitt, MD, MBBS, FRCPC



The Light-er Side of Treating Seasonal Affective Disorder

October 01, 2005

Seasonal affective disorder affects 1% to 3% of the North American population. Evidence exists for the efficacy of high-intensity bright, fluorescent light. Pharmacological management with SSRIs has shown equivalent efficacy to light therapy. How can these two therapies be combined? What other therapies are available?